Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Market Cap: 165.6B DKK
Have any thoughts about
Novozymes A/S?
Write Note

Net Margin
Novozymes A/S

16.9%
Current
20%
Average
4.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.9%
=
Net Income
3B
/
Revenue
17.9B

Net Margin Across Competitors

Country DK
Market Cap 165.6B DKK
Net Margin
17%
Country US
Market Cap 97.8B USD
Net Margin
11%
Country JP
Market Cap 11.2T JPY
Net Margin
21%
Country US
Market Cap 69.8B USD
Net Margin
13%
Country CH
Market Cap 36.3B CHF
Net Margin
15%
Country US
Market Cap 34.8B USD
Net Margin
7%
Country CN
Market Cap 232B CNY
Net Margin
8%
Country CH
Market Cap 28.5B EUR
Net Margin
20%
Country US
Market Cap 28.5B USD
Net Margin
8%
Country IN
Market Cap 2.4T INR
Net Margin
14%
Country US
Market Cap 23.2B USD
Net Margin
-20%
No Stocks Found

Novozymes A/S
Glance View

Market Cap
165.6B DKK
Industry
Chemicals

Novozymes A/S is a global leader in biotechnology, focusing on the production of enzymes and microorganisms that enhance industrial processes. Founded in 1925 and based in Denmark, the company has consistently leveraged its deep scientific expertise to innovate solutions across various sectors, including agriculture, bioenergy, and food & beverage. By developing sustainable alternatives to traditional chemical processes, Novozymes not only improves efficiency for its clients but also helps minimize environmental impact. As industries continue to shift towards greener practices, Novozymes stands at the forefront of this transition, positioning itself as a pivotal player committed to driving sustainable development. For investors, Novozymes represents a compelling opportunity in a growing market driven by increasing awareness of sustainability and resource efficiency. The company boasts a diverse portfolio of products and a strong track record of profitability, sustained by its continuous investment in research and development. With a robust customer base spanning across more than 30 industries, Novozymes is well-equipped to capitalize on the expanding demand for bio-based solutions. Investors can find confidence in Novozymes' strategic focus on innovation and its ability to adapt to the evolving landscape of global sustainability goals, making it a strong candidate for those looking to invest in a future-oriented enterprise.

NZYM B Intrinsic Value
124.85 DKK
Overvaluation 69%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.9%
=
Net Income
3B
/
Revenue
17.9B
What is the Net Margin of Novozymes A/S?

Based on Novozymes A/S's most recent financial statements, the company has Net Margin of 16.9%.